Overview: Who Is HK Peptides Worldwide?
HK Peptides Worldwide is an international research peptide supplier operating at hkpeptidesworldwide.com with over 74 active product listings indexed on Peptides.SO. The company's "worldwide" designation reflects a deliberate international focus — international shipping capability and a catalog architecture designed to serve research institutions, independent investigators, and laboratory teams across diverse geographic markets.
HK Peptides Worldwide organizes its entire catalog under a single "Research Grade Peptide" classification, signaling a focused commitment to the peptide research vertical rather than a broader research chemicals model. All products are sold exclusively for laboratory and in-vitro scientific purposes. Compounds are not approved for human consumption, clinical application, or veterinary use, and researchers should handle all materials in accordance with applicable institutional biosafety protocols and regional regulatory frameworks.
> Research Use Only (RUO) Disclaimer: All products from HK Peptides Worldwide are intended solely for laboratory research, in-vitro scientific investigation, and educational purposes. They are not for human use, veterinary application, or clinical administration.
---
Catalog Breadth: 74+ Listings Across the Major Research Peptide Families
With 74 active listings concentrated in the Research Grade Peptide category, HK Peptides Worldwide provides coverage across the principal peptide families driving contemporary biomedical and longevity research. The catalog reflects a research-demand-aligned structure rather than an exhaustive mass-market approach.
GLP-1 Receptor Agonist Compounds
GLP-1 pharmacology sits at the center of current metabolic disease research, and HK Peptides Worldwide maintains substantial depth in this segment. Semaglutide — the most widely studied GLP-1 receptor agonist in the literature — is available, supporting both dose-response and mechanism-of-action study designs. Tirzepatide, the dual GLP-1/GIP receptor co-agonist, extends coverage to dual-incretin pharmacology research. Liraglutide rounds out the GLP-1 class with a compound that has accumulated one of the larger preclinical datasets in the field.
For researchers working on GLP-1 receptor binding kinetics, incretin-mimetic metabolic effects, or comparative agonist studies, the depth here removes the need for a second supplier in this segment.
Retatrutide (LY3437943) — Eli Lilly's Phase 3 triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously — receives notable catalog depth at HK Peptides Worldwide, with seven SKUs spanning 10 mg through 60 mg formats. This tiered dosing range is significant: multi-dose cohort designs and extended in-vitro protocols require access to both entry-level and high-quantity formats, and the full 10–60 mg ladder accommodates both. Cagrilinitide (CAG), the amylin/GLP-1 combination compound studied for additive weight reduction effects, is also available, supporting researchers tracking the next generation of combinatorial metabolic interventions.
Growth Hormone Secretagogue Segment
The GH secretagogue lineup at HK Peptides Worldwide covers the standard GHRH and GHRP analogue stack studied in GH pulse amplitude modulation, pituitary function, and IGF-1 axis signaling research:
- •CJC-1295 with DAC — the long-acting GHRH analogue; available in 10 mg format
- •Ipamorelin — selective GHRP with minimal off-target cortisol or prolactin activity
- •GHRP-2 and GHRP-6 — first-generation GHRPs with distinct appetite-stimulating profiles relevant to appetite and metabolic research
- •Hexarelin — high-potency GHRP with additional ghrelin receptor activity
- •Sermorelin — shorter-acting endogenous GHRH analogue; 10 mg format
- •Tesamorelin — the FDA-approved GHRH analogue (Egrifta); available in both 5 mg and 10 mg formats
- •MK-677 (Ibutamoren) — oral GH secretagogue extending coverage to non-peptide GH stimulation research contexts
The GHRH/GHRP pairing options — Sermorelin, CJC-1295, and the standard GHRPs — allow researchers studying synergistic GH pulse amplification to source the full combination stack from a single supplier. Tesamorelin's presence connects the catalog to FDA-approved compound pharmacology.
Tissue Repair and Regeneration
BPC-157 and TB-500 (Thymosin Beta-4) are available individually and in a pre-blended 20 mg combination vial — a format that reduces researcher preparation steps for multi-peptide experimental protocols. BPC-157 in particular has accumulated substantial preclinical data in gastrointestinal mucosal healing, tendon repair, and angiogenesis models. TB-500's role in actin-binding and cell migration research makes the pairing a standard combination for tissue injury recovery studies.
Melanocortin and Sexual Function Research
The melanocortin segment includes Melanotan-I, Melanotan-II, and PT-141/Bremelanotide — covering both MC1R (pigmentation) and MC4R (central melanocortin signaling) receptor ligand research. PT-141 (Bremelanotide) carries FDA approval as Vyleesi for hypoactive sexual desire disorder, giving this compound a recognized clinical pharmacology basis that supports legitimate receptor biology research contexts.
Longevity, Immunology, and Skin Biology
- •Epithalon — tetrapeptide studied in telomerase activation and age-related gene expression in cellular and animal models
- •Thymosin Alpha-1 — immunomodulatory compound with established thymic biology research applications
- •GHK-Cu — copper peptide with skin biology and wound-healing research relevance, available in injectable and topical formulations
---
Quality and Purity Verification
HK Peptides Worldwide applies third-party analytical testing to verify compound purity across the catalog. HPLC (high-performance liquid chromatography) provides the primary purity readout, while mass spectrometry analysis confirms molecular identity. This two-technique verification approach — HPLC for purity percentage, MS for structure confirmation — represents the standard used by higher-quality research peptide suppliers.
Certificate of Analysis (COA) documentation is made available per product, allowing researchers to review batch-specific test data before incorporating compounds into experimental protocols. For researchers working in institutional settings where source documentation may be required by biosafety committees or IRBs, COA availability reduces sourcing friction.
The consistent "Research Grade Peptide" categorization across all 74+ listings reflects a catalog built specifically around analytical-grade research materials rather than a general supplement or fitness compound model.
---
Pricing Structure
HK Peptides Worldwide's pricing reflects an international research supplier positioning. The multi-SKU depth on high-demand compounds like Retatrutide — available at seven quantity tiers from 10 mg through 60 mg — suggests a tiered pricing architecture designed to accommodate both pilot-scale research acquisitions and extended multi-cohort study procurement.
Combination products (such as the BPC-157/TB-500 blend) and alternative delivery formats (nasal sprays, oral formulations in select compounds) carry distinct pricing from standard lyophilized vials, reflecting differences in formulation complexity and preparation overhead that blended or alternative-route formats eliminate for the researcher.
Specific current pricing is best verified directly on the HK Peptides Worldwide website, as catalog prices reflect live inventory and market conditions.
---
Ordering, Shipping, and Delivery
HK Peptides Worldwide ships internationally with tracking, positioning the company as a viable source for research programs outside the US domestic market. The website operates on a standard e-commerce model accessible through hkpeptidesworldwide.com.
Delivery format options extend beyond the standard lyophilized vial: select compounds are available as nasal sprays and oral formulations, giving researchers studying peptide bioavailability or alternative administration route pharmacokinetics access to pre-formulated materials without requiring in-house preparation. For laboratory teams without dedicated compounding capability, this format flexibility is a practical operational advantage.
---
Pros and Cons
Pros:
- •74+ listings covering all major research peptide families from one supplier
- •International shipping with tracking to multiple geographic markets
- •Third-party HPLC + mass spectrometry testing with COA documentation per product
- •Multi-SKU depth on high-demand compounds (Retatrutide at 7 dose tiers)
- •Alternative delivery formats: nasal spray and oral options in select compounds
- •Combination/blended products reduce researcher prep overhead
- •Full GH secretagogue stack (CJC-1295, Ipamorelin, GHRP-2, GHRP-6, Hexarelin, Sermorelin) available from a single supplier
Cons:
- •No verified quality score or site rating yet — new to the Peptides.SO index (joined March 2026)
- •Pricing not publicly aggregated; requires direct website verification
- •Location listed as "Unknown" — less geographic transparency than US-domestic suppliers
- •No Trustpilot or third-party review score available at time of writing
---
Verdict: Who Should Consider HK Peptides Worldwide?
HK Peptides Worldwide is best suited to researchers who need catalog breadth across multiple peptide families — particularly those working on GLP-1 pharmacology, GH secretagogue axis biology, or multi-compound tissue repair protocols — from a single international supplier with analytical documentation.
The depth in GLP-1 class compounds (Semaglutide, Tirzepatide, Retatrutide, Cagrilinitide) is notable and reflects an actively maintained catalog tracking the frontier of metabolic research compound demand. The seven-tier Retatrutide SKU structure in particular is unusual at this granularity and useful for researchers running dose-response designs at the preclinical scale.
The main caveat is the absence of an established review record: HK Peptides Worldwide entered the Peptides.SO index in March 2026, and no community review history or Trustpilot data is yet available. Researchers sourcing from an unfamiliar international supplier for the first time should verify COA documentation carefully and consider starting with a single-compound order before committing to multi-compound procurement.
For established research programs requiring international sourcing access with multi-family compound coverage and documented purity verification, HK Peptides Worldwide merits evaluation as a primary or secondary supplier.
---
All compounds available through HK Peptides Worldwide are sold for research use only (RUO). Products are not approved by the FDA or equivalent regulatory agencies for human consumption, clinical use, or veterinary application. Researchers are responsible for compliance with all applicable federal, state, and institutional regulations governing the acquisition, storage, and use of research compounds.